Natixis Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-86,094
Closed -$207K 1610
2024
Q1
$207K Buy
+86,094
New +$185K ﹤0.01% 1518
2023
Q3
Sell
-87,425
Closed -$200K 1514
2023
Q2
$200K Sell
87,425
-80
-0.1% -$212 ﹤0.01% 1468
2023
Q1
$213K Buy
+87,505
New +$201K ﹤0.01% 1455
2022
Q4
Sell
-88,411
Closed -$212K 1486
2022
Q3
$212K Buy
+88,411
New +$245K ﹤0.01% 1432
2022
Q1
Sell
-93,969
Closed -$370K 1450
2021
Q4
$370K Sell
93,969
-568
-0.6% -$2.76K ﹤0.01% 1291
2021
Q3
$455K Sell
94,537
-208
-0.2% -$854 ﹤0.01% 1223
2021
Q2
$435K Sell
94,745
-114
-0.1% -$549 ﹤0.01% 1227
2021
Q1
$556K Sell
94,859
-6,134
-6% -$42.5K ﹤0.01% 1153
2020
Q4
$345K Buy
+100,993
New +$193K ﹤0.01% 1165

Other funds holding LXRX